Status:
UNKNOWN
Group A Pharyngitis in Children: The GASPARD Study
Lead Sponsor:
Klara Posfay-Barbe
Collaborating Sponsors:
Gertrude Von Meissner Foundation
Recherche et Développement des HUG
Conditions:
Group A Streptococcal Pharyngitis
Eligibility:
All Genders
3-15 years
Phase:
PHASE4
Brief Summary
Evaluate the necessity to treat with antibiotics GAS pharyngitis in children in Switzerland. The null hypothesis is that antibiotic treatment is not necessary for GAS pharyngitis in this population.
Detailed Description
All children between 3 -15 years old with clinical symptoms suggestive of pharyngitis (Mc Isaac score ≥3) and a microbiological test (rapid antigen detection) positive for group A Streptococcus (GAS) ...
Eligibility Criteria
Inclusion
- 3 -15 years old
- Clinical symptoms suggestive of pharyngitis with MC Isaac score ≥3
- Rapid-antigen detection test (RADT) positive for GAS-
- Signed informed parental/patient consent form
Exclusion
- Hypersensitivity to B-lactams
- concomitant disease which must be treated with antibiotics
- chronic disease-Immunocompromised
- Antibiotics within 72 h
- history of ARF,scarlet fever,impetigo,acute glomerulonephritis
- Family history of ARF
- Complicated pharyngitis
Key Trial Info
Start Date :
January 27 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2018
Estimated Enrollment :
360 Patients enrolled
Trial Details
Trial ID
NCT03264911
Start Date
January 27 2017
End Date
December 31 2018
Last Update
August 29 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital of Geneva (HUG)
Geneva, Canton of Geneva, Switzerland, 1211